Naresh Kumar
Naresh Kumar, New South Wales AU
Patent application number | Description | Published |
---|---|---|
20080306140 | Isoflavonoid Dimers - Novel compounds based on phenyl-substituted naphtho[1,2-g]chrysene compounds (A) are described. The compounds are obtainable by dimerisation of 3-phenylchroman (isoflavonoid) ring systems (B). Methods of synthesis of the novel dimeric compounds, compositions containing same and use of the dimers as therapeutic agents are also described. | 12-11-2008 |
20100035948 | Furanone compounds and lactam analogues thereof - The present invention provides a compound of formula I and a compound of formula II, methods of use and formulations thereof. | 02-11-2010 |
20110046722 | OXAZINYL ISOFLAVONOID COMPOUNDS, MEDICAMENTS AND USE - The invention provides oxazinyl isoflavonoid compounds and compositions containing same, methods for their preparation and their use as therapeutic agents particularly as cardioprotective, anti-inflammatory, anti-oxidant and chemotherapeutic agents. | 02-24-2011 |
Naresh Kumar, New Delhi IN
Patent application number | Description | Published |
---|---|---|
20100112106 | SYNERGISTIC HERBAL OPHTHALMIC FORMULATION FOR LOWERING THE INTRA OCULAR PRESSURE IN CASE OF GLAUCOMA - The present invention relates to a synergistic herbal composition for lowering the intra ocular pressure in different types of glaucoma and process for the preparation of the same in pharmaceutically acceptable dosage forms. | 05-06-2010 |
Naresh Kumar, Gurgaon Haryana IN
Patent application number | Description | Published |
---|---|---|
20100035954 | ACID ADDITION SALTS OF MUSCARINIC RECEPTOR ANTAGONISTS - Provided herein are acid addition salts of muscarinic receptor antagonists. Such acid addition salts are muscarinic receptor antagonists, which are useful, among other uses, for the treatment of various diseases of the respiratory, urinary and gastrointestinal systems mediated through muscarinic receptors. Also provided herein are processes for the preparation of acid addition salts, pharmaceutical compositions thereof, and methods of treating diseases mediated through muscarinic receptors. | 02-11-2010 |
Naresh Kumar, South Riding, VA US
Patent application number | Description | Published |
---|---|---|
20090319596 | SYSTEM AND METHOD FOR BILLING SYSTEM INTERFACE FAILOVER RESOLUTION - A determination is made whether a first application server of a group of N application servers, N being at least two, is a coordinator of the group. Responsive to determining that the first application server is the coordinator of the group, a connection to a billing system is established, via a terminal server, by the first application server. A determination is made whether a second application server of the group of N application servers is the coordinator of the group. Responsive to determining that the second application server is not the coordinator of the group, a periodic check is made whether the second application server of the group of N application servers is the coordinator of the group. The second application server may later be determined to be the coordinator of the group, when the first server experiences difficulty. Once it is determined that the second application server now is the coordinator of the group, a connection is established to the billing system, via the terminal server, by the second application server. | 12-24-2009 |
20110283003 | SYSTEM AND METHOD FOR BILLING SYSTEM INTERFACE FAILOVER RESOLUTION - A determination is made whether a first application server of a group of N application servers, N being at least two, is a coordinator of the group. Responsive to determining that the first application server is the coordinator of the group, a connection to a billing system is established, via a terminal server, by the first application server. A determination is made whether a second application server of the group of N application servers is the coordinator of the group. Responsive to determining that the second application server is not the coordinator of the group, a periodic check is made whether the second application server of the group of N application servers is the coordinator of the group. The second application server may later be determined to be the coordinator of the group, when the first server experiences difficulty. Once it is determined that the second application server now is the coordinator of the group, a connection is established to the billing system, via the terminal server, by the second application server. | 11-17-2011 |
Naresh Kumar, Maroubra AU
Patent application number | Description | Published |
---|---|---|
20090048461 | Regulators of Bacterial Signalling Pathways - The present invention provides a method for the preparation of compounds of formula (II). The invention also provides novel compounds of formula (II) and their use in medical, scientific and/or biological applications. | 02-19-2009 |
20120003270 | 6-SUBSTITUTED ISOFLAVONOID COMPOUNDS AND USES THEREOF - The present invention relates to 6-substituted isoflavonoid compounds and compositions comprising same. The invention further relates to the use of 6-substituted isoflavonoid compounds for the treatment of various diseases and conditions. | 01-05-2012 |
20130190377 | Novel Lactams - The present invention relates to novel lactams of formulae (I) and (II). The present invention further relates to the use of these compounds in the treatment of microbial infections and microbial contamination of surfaces, particularly infections and surface contaminations characterised by biofilm formation. Further provided are compounds of formula (I) and (II) substituted with acrylate or methacrylate groups and their attachment to surfaces or polymers to inhibit microbial contamination. | 07-25-2013 |
Naresh Kumar, Indianapolis, IN US
Patent application number | Description | Published |
---|---|---|
20140187554 | MODULATORS OF THE NUCLEAR HORMONE RECEPTOR ROR - The invention provides small molecule modulators of retinoic acid receptor-related orphan receptors such as RORα, RORβ, or RORγ. Compounds of the invention can be effective modulators at concentrations ineffective to act on LXR receptors, or on other nuclear receptors, or other biological targets. Methods of modulation the RORs and methods of treating metabolic disorders, immune disorders, cancer, and CNS disorders wherein modulation of an ROR is medically indicated are also provided. | 07-03-2014 |
Naresh Kumar, Stone Ridge, VA US
Patent application number | Description | Published |
---|---|---|
20150127750 | System and Method for Pushing Smart Alerts - An alert notification is received and evaluated by a processor. An identifier of a subscriber who is registered to receive the first alert notification is identified. The subscriber identifier is used to select assessment rules corresponding to the first alert notification. The assessment rules are applied to the alert notification to determine whether the receipt of the alert notification satisfies a condition for taking one or more actions. If the condition is met, one or more commands are issued to effectuate the one or more actions. | 05-07-2015 |
Naresh Kumar, Faridabad IN
Patent application number | Description | Published |
---|---|---|
20150152199 | ZIEGLER-NATTA CATALYST SYSTEMS COMPRISING A 1,2-PHENYLENEDIOATE AS INTERNAL DONOR AND PROCESS FOR PREPARING THE SAME - A catalyst composition for use as precursor for Ziegler-Natta catalyst system, said catalyst composition comprising a combination of magnesium moiety, titanium moiety and an internal donor containing at least one 1,2-phenylenedioate compound of structure (A). Also, the present invention provides a process for preparing the aforesaid catalyst composition. Further, the present invention provides a Ziegler-Natta catalyst system incorporating the aforesaid catalyst composition and a method for polymerizing and/or copolymerizing olefins using the Ziegler-Natta catalyst system. | 06-04-2015 |